Prevalence and factors associated with depression in patients with chronic obstructive pulmonary disease from a comprehensive care program in Bogotá. 2017-2018

Autor: Quintero Gonzalez, Luz Adriana, Rosas, Sara

Publikováno v: 1. WHO. No Title [Internet]. Las 10 principales causas de defuncion en el mundo. 2015. Disponible en: http://www.who.int/mediacentre/factsheets/fs310/es/
2. Cerezo Lajas A, Puente Maestu L, de Miguel Díez J. Relevance of comorbidity in chronic obstructive pulmonary disease (COPD). Rev Patol Respir [Internet]. 2019;22(3):81–3.
3. Menezes AMB, Perez-Padilla R, Jardim JB, Muiño A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet [Internet]. 2017 Apr 19;366(9500):1875–81. Disponible en: http://dx.doi.org/10.1016/S0140-6736(05)67632-5
4. Caballero A, Torres-Duque CA, Jaramillo C, Bolívar F, Sanabria F, Osorio P, et al. Prevalence of COPD in Five Colombian Cities Situated at Low, Medium, and High Altitude (PREPOCOL Study). Chest [Internet]. 2008 [cited 2017 Apr 2];133(2):343–9. Disponible en: https://doi.org/10.1378/chest.07-1361
5. Yaneth Gil Rojas, Carlos A. Torres Duque, María del Carmen Figueredo, Fabián Hernández, Camilo Castañeda Cardona, Pieralessandro Lasalvia Dr. Estimación De La Prevalencia De Epoc En Colombia A Partir Del Registro Individual De Prestaciones De Servicios De Salud (RIPS). Rev Colomb Neumol [Internet]. 2109;31. Disponible en: http://dx.doi.org/10.30789/rcneumologia.v31.n1.2019.325
6. Perez-Padilla R, Menezes AMB. Chronic obstructive pulmonary disease in Latin America. Ann Glob Heal. 2019;85(1):1–11
7. Negewo, Netsanet & Gibson, Peter & Mcdonald V. COPD and its comorbidities: Impact, measurement and mechanisms. Respirol (Carlton, Vic) [Internet]. 2015; Disponible en: https://doi.org/10.1111/resp.12642
8. WHO. Depresion-WHO. Available from: https://www.who.int/es/news-room/fact-sheets/detail/depression
9. Salazar AM. Prevalencia y factores de riesgo psicosociales de la depresión en un grupo de adultos mayores en Bogotá Prevalence and psychosocial risk factors of depression in a group of older adults in Bogota Trabajo original. Acta Neurol Colomb. 2015;31(2):176–83.
11. Lou P, Zhu Y, Chen P, Zhang P, Yu J, Zhang N, et al. Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study. BMC Pulm Med. 2012 Sep;12:53
12. Montserrat-Capdevila J, Godoy P, Marsal JR, Barbé F, Pifarré J, Alsedà M, et al. Overview of the Impact of Depression and Anxiety in Chronic Obstructive Pulmonary Disease. Lung. 2017;195(1):77–85.
13. Castro-Benites VA, Runzer-Colmenares FM, Parodi JF. Depresión en pacientes adultos mayores de comunidades de altura, con enfermedad pulmonar obstructiva crónica (EPOC). Rev Neuropsiquiatr. 2019;82(1):4
14. Gómez-Restrepo C. La Encuesta Nacional de Salud Mental–ENSM 2015. Vol. 45, Revista Colombiana de Psiquiatria. 2016. 1 p
15. Menezes AMB, Victora CG, Perez-Padilla R. The Platino project: Methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities. BMC Med Res Methodol. 2004;4:1–7
16. Maurer J, Rebbapragada V, Borson S, Goldstein R, ME K, AM Y, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. [Internet]. Vol. 134, Chest. 2008. p. 43S-43S-56S. Disponible en: https://doi.org/10.1378/chest.08-0342
17. Caballero A, CA T-D, Jaramillo C, Bolívar F, Sanabria F, Osorio P, et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). [Internet]. Vol. 133, Chest. 2008. p. 343–9. Disponible en: https://doi.org/10.1378/chest.07-1361
18. Carol Kelly, RGN, MA, BSc, is senior lecturer; Dave Lynes, PhD, RGN, is academic lead/head of academic services; both at Edge Hill University, Lancashire/Respiratory Education UK L. Psychological effects of chronic lung disease. Nurs Times [Internet]. 2008
19. Lou P, Zhu Y, Zhao J. Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China : a cross-sectional case control study Background Trial registration Methods Sampling strategy. 2015;1–9
20. Hanania NA, Müllerova H, Locantore NW, Vestbo J, Watkins ML, Wouters EFM, et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med. 2011;183(5):604–11
21. Yohannes AM, Mülerová H, Lavoie K, Vestbo J, Rennard SI, Wouters E, et al. The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort. J Am Med Dir Assoc [Internet]. 2017;18(11):955-959.e6. Disponible en: https://doi.org/10.1016/j.jamda.2017.05.024
22. Tomas Baader M, José Luis Molina F, Silvia Venezian B, Carmen Rojas C, Renata Farías S, Fierro-Freixenet C, et al. Validación y utilidad de la encuesta PHQ-9 (Patient Health Questionnaire) en el diagnóstico de depresión en pacientes usuarios de atención primaria en Chile. Rev Chil Neuropsiquiatr. 2012;50(1):10–22. Disponible en: http://dx.doi.org/10.4067/S0717-92272012000100002
24. Blakemore A, Dickens C, Guthrie E, Bower P, Kontopantelis E, Afzal C, et al. Depression and anxiety predict health-related quality of life in chronic obstructive pulmonary disease: Systematic review and meta-analysis. Int J COPD. 2014;9:501–12.
25. Marín JM. Principales parámetros de función pulmonar en la enfermedad pulmonar obstructiva crónica ( EPOC ). Aten Primaria. 2003;32(3):169–76
26. C. Casanova Macarioa, I. García-Talavera Martínb J de TT. La disnea en la EPOC. Arch Bronconeumol. 2005;41(3):24–32.
27. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012 Jul;186(2):155–61
28. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.
29. Lajas A, Maestu L, Díez J. Relevancia de la comorbilidad en la EPOC. Rev Patol Respir [Internet]. 2019;22(3):81–3.
30. Jones PW. St George ’ S Respiratory Questionnaire. 2009;44(June):0–16.
31. Ferrer M, Alonso J, Prieto L, Plaza V, Monsó E, Marrades R, et al. Validity and reliability of the St George’s respiratory questionnaire after adaptation to a different language and culture: The Spanish example. Eur Respir J. 1996;9(6):1160–6.
32. Del V, Respiratorio C, George ST, Evaluar P, Vida CDE, Pacientes EN, et al. Validation of Respiratory Questionnaire St . George for Assessing Quality of Life. 2015;6(1)
33. Baader T, Molina J, Venezian S, Rojas C, Farías R, Fierro-Freixenet C, et al. Validación y utilidad de la encuesta PHQ-9 (Patient Health Questionnaire) en el diagnóstico de depresión en pacientes usuarios de atención primaria en Chile. Rev Chil Neuropsiquiatr [Internet]. 2012;9(1):10–22. Disponible en: http://dx.doi.org/10.4067/S0717-92272012000100002
34. Cassiani-Miranda CA, Cuadros-Cruz AK, Torres-Pinzón H, Scoppetta O, Pinzón-Tarrazona JH, López-Fuentes WY, et al. Validity of the Patient Health Questionnaire-9 (PHQ-9) for depression screening in adult primary care users in Bucaramanga, Colombia. Rev Colomb Psiquiatr [Internet]. 2020;(x x). Disponible en: https://doi.org/10.1016/j.rcp.2019.09.001
35. Cassiani-Miranda CA, Vargas-Hernández MC, Pérez-Aníbal E, Herazo-Bustos MI, Hernández-Carrillo M. Confiabilidad y dimensión del cuestionario de salud del paciente (PHQ-9) para la detección de síntomas de depresión en estudiantes de ciencias de la salud en Cartagena, 2014. Biomedica. 2017;37:112–20.
36. Saldivia S, Aslan J, Cova F, Vicente B, Inostroza C, Rincón P. Propiedades psicométricas del PHQ-9 (Patient Health Questionnaire) en centros de atención primaria de Chile. Rev Med Chil. 2019;147(1):53–60.
37. Schueller SM, Kwasny MJ, Dear BF, Titov N, Mohr DC. Cut points on the Patient Health Questionnaire (PHQ-9) that predict response to cognitive-behavioral treatments for depression. Gen Hosp Psychiatry [Internet]. 2015;37(5):470–5. Disponible en: http://dx.doi.org/10.1016/j.genhosppsych.2015.05.009
38. Thapa N, Maharjan M, Shrestha TM, Gauchan S, Pun P, Thapa YB. Anxiety and depression among patients with chronic obstructive pulmonary disease and general population in rural Nepal. BMC Psychiatry. 2017;17(1):1–7. DOI: 10.1186/s12888-017-1550-5
39. Agarwal A, Batra S, Prasad R, Verma A, Jilani AQ, Kant S. A study on the prevalence of depression and the severity of depression in patients of chronic obstructive pulmonary disease in a semi-urban Indian population. Monaldi Arch Chest Dis. 2018;88(1):54–60. doi: 10.4081/monaldi.2018.902
40. Von Siemens SM, Jörres RA, Behr J, Alter P, Lutter J, Lucke T, et al. Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: Results from the COSYCONET cohort study. Respir Res. 2019;20(1):1–11. https://doi.org/10.1186/s12931-019-0997-y
41. The Jamovi Project. (2020).Jamovi.(version 1.2)(computer software).Retrieved from [Internet]. Disponible en: https://www.jamovi.org/
42. González-Gutiérrez MV, Guerrero Velázquez J, Morales García C, Casas Maldonado F, Gómez Jiménez FJ, González Vargas F. Predictive Model for Anxiety and Depression in Spanish Patients with Stable Chronic Obstructive Pulmonary Disease. Arch Bronconeumol. 2016;52(3):151–7. doi: 10.1016/j.arbres.2015.09.003
43. Xiao T, Qiu H, Chen Y, Zhou X, Wu K, Ruan X, et al. Prevalence of anxiety and depression symptoms and their associated factors in mild COPD patients from community settings, Shanghai, China: A cross-sectional study. BMC Psychiatry. 2018;18(1):1–7. doi: 10.1186/s12888-018-1671-5
44. Matte DL, Pizzichini MMM, Hoepers ATC, Diaz AP, Karloh M, Dias M, et al. Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies. Respir Med [Internet]. 2016;117:154–61. Disponible en: http://dx.doi.org/10.1016/j.rmed.2016.06.006
45. Ministerio de salud Colombia. Boletín de salud mental Depresión Subdirección de Enfermedades No Transmisibles. Boletín salud Ment Depresión Subdirección Enfermedades No Transm [Internet]. 2017;2:0–16. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/ENT/boletin-depresion-marzo-2017.pdf
46. Putman-Casdorph H, McCrone S. Chronic obstructive pulmonary disease, anxiety, and depression: State of the science. Hear Lung J Acute Crit Care [Internet]. 2009;38(1):34–47. Disponible en: http://dx.doi.org/10.1016/j.hrtlng.2008.02.005
47. Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F, et al. Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med. 2006;100(10):1767–74. doi: 10.1016/j.rmed.2006.01.026
48. Varol Y, Anar C, Çimen P, Ünlü M, Halilçolar H, Güçlü SZ. Sex-related differences in COPD assessment test scores of COPD populations with or without significant anxiety and/or depression. Turkish J Med Sci. 2017;47(1):61–8. doi: 10.3906/sag-1509-60.
49. Lee JH, Park MA, Park MJ, Jo YS. Clinical characteristics and related risk factors of depression in patients with early COPD. Int J COPD. 2018;13:1583–90. doi: 10.2147/COPD.S157165. eCollection 2018.
50. Xu K, Li X. Risk factors for depression in patients with chronic obstructive pulmonary disease. Med Sci Monit. 2018;24:1417–23. doi: 10.12659/MSM.904969
51. Dolores M, Rubio N, Albert I, Salud JJ De. Cuidadores de pacientes con enfermedades respiratorias : El caso de la EPOC. 2016;9(2):43–50.
52. Akasheh N, Byrne D, Coss P, Conway R, Cournane S, O’Riordan D, et al. Lung function and outcomes in emergency medical admissions. Eur J Intern Med [Internet]. 2019;59(July 2018):34–8. Disponible en: https://doi.org/10.1016/j.ejim.2018.09.010
53. Iyer AS, Bhatt SP, Garner JJ, Wells JM, Trevor JL, Patel NM, et al. Depression is associated with readmission for acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2016;13(2):197–203. doi: 10.1513/AnnalsATS.201507-439OC
54. Lecheler L, Richter M, Franzen DP, Rampini SK, Cheetham M, Jenewein J, et al. The frequent and underrecognised co-occurrence of acute exacerbated COPD and depression warrants screening: A systematic review. Eur Respir Rev [Internet]. 2017;26(144). Disponible en: http://dx.doi.org/10.1183/16000617.0026-2017
55. Soler-Cataluña JJ, Sauleda J, Valdés L, Marín P, Agüero R, Pérez M, et al. Prevalencia y percepción de la variabilidad diaria de los síntomas en pacientes con enfermedad pulmonar obstructiva crónica estable en España. Arch Bronconeumol. 2016;52(6):308–15. http://dx.doi.org/10.1016/j.arbres.2015.11.010
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario

La depresión es una comorbilidad conocida de la EPOC, aunque el diagnóstico no es frecuente. Este estudio estableció la prevalencia de depresión y factores asociados en pacientes de un programa de atención integral. Introducción: La depresión

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6565b0f7f6ab419913cefac01c18c0c9